Oppenheimer Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Sell
12,775
-1,621
-11% -$481K 0.04% 394
2025
Q4
$3.93M Buy
14,396
+3,264
+29% +$887K 0.05% 352
2025
Q3
$3.01M Sell
11,132
-401
-3% -$109K 0.03% 454
2025
Q2
$3.18M Sell
11,533
-3,331
-22% -$906K 0.04% 440
2025
Q1
$3.94M Sell
14,864
-107
-0.7% -$26.4K 0.05% 365
2024
Q4
$3.48M Buy
14,971
+353
+2% +$81.2K 0.04% 405
2024
Q3
$3.23M Sell
14,618
-17,913
-55% -$3.71M 0.04% 423
2024
Q2
$6.4M Buy
32,531
+5,224
+19% +$1.08M 0.08% 267
2024
Q1
$5.88M Buy
27,307
+1,089
+4% +$229K 0.09% 258
2023
Q4
$5.52M Buy
26,218
+389
+2% +$83K 0.08% 284
2023
Q3
$5.17M Sell
25,829
-696
-3% -$138K 0.08% 272
2023
Q2
$4.91M Buy
26,525
+6,308
+31% +$1.17M 0.07% 289
2023
Q1
$3.87M Buy
20,217
+2,961
+17% +$535K 0.06% 326
2022
Q4
$2.9M Sell
17,256
-4,169
-19% -$724K 0.05% 386
2022
Q3
$3.79M Sell
21,425
-3,270
-13% -$646K 0.07% 295
2022
Q2
$5.05M Sell
24,695
-544
-2% -$115K 0.08% 254
2022
Q1
$6M Sell
25,239
-1,755
-7% -$412K 0.09% 261
2021
Q4
$6.17M Buy
26,994
+256
+1% +$56.3K 0.08% 265
2021
Q3
$5.17M Sell
26,738
-2,010
-7% -$407K 0.07% 293
2021
Q2
$6.11M Sell
28,748
-412
-1% -$87K 0.09% 267
2021
Q1
$5.96M Buy
29,160
+24,972
+596% +$4.92M 0.09% 254
2020
Q4
$761K Sell
4,188
-2,235
-35% -$380K 0.01% 771
2020
Q3
$1.08M Sell
6,423
-18,936
-75% -$3.19M 0.02% 592
2020
Q2
$4.12M Sell
25,359
-29
-0.1% -$5.2K 0.09% 267
2020
Q1
$4.39M Buy
25,388
+764
+3% +$152K 0.11% 210
2019
Q4
$4.94M Sell
24,624
-1,345
-5% -$276K 0.1% 232
2019
Q3
$5.49M Sell
25,969
-636
-2% -$133K 0.12% 206
2019
Q2
$5.16M Buy
26,605
+5,405
+25% +$996K 0.11% 216
2019
Q1
$3.49M Sell
21,200
-1,529
-7% -$270K 0.08% 278
2018
Q4
$4.28M Sell
22,729
-996
-4% -$184K 0.11% 224
2018
Q3
$4.04M Sell
23,725
-362
-2% -$60.9K 0.09% 264
2018
Q2
$3.95M Sell
24,087
-752
-3% -$123K 0.1% 257
2018
Q1
$4.02M Sell
24,839
-2,392
-9% -$381K 0.1% 249
2017
Q4
$3.69M Hold
27,231
0.1% 247
2017
Q3
$3.69M Sell
27,231
-468
-2% -$59.1K 0.1% 249
2017
Q2
$3.47M Sell
27,699
-431
-2% -$51.5K 0.1% 241
2017
Q1
$3.34M Buy
+28,130
New +$3.38M 0.1% 247

Other funds holding CME

Oppenheimer Asset Management's CME Position: Q1 2026 in Review

Oppenheimer Asset Management reduced its CME Group (CME) stake by 11% in Q1 2026, selling an estimated $481K and leaving 12,775 shares worth $3.77M. The position accounts for 0.04% of the portfolio, ranked #394.

Oppenheimer Asset Management first reported a position in CME in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.4M in Q2 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Oppenheimer Asset Management held 12,775 shares of CME Group worth $3.77M as of Q1 2026.
  • Oppenheimer Asset Management sold 1,621 CME Group shares in Q1 2026, an estimated $481K.
  • CME Group made up 0.04% of Oppenheimer Asset Management's portfolio in Q1 2026, its #394 holding.
  • Oppenheimer Asset Management first reported a position in CME Group in Q1 2017 and has held it in 37 quarters since.
  • Oppenheimer Asset Management's CME Group position peaked at $6.4M in Q2 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.